About Us Contact Us Sitemap

Genomic Cancer Panel and Profiling Market, By Testing Type (Comprehensive Genomic Profiling (CGP), Targeted Gene Panels, Whole Genome Sequencing (WGS), and Whole Exome Sequencing (WES)), By Technology, By Cancer Type, By End-Use, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Market Research Image
Report ID AV5516
Published Date July 2026
Pages 418
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Genomic Cancer Panel and Profiling Market size was valued at USD 11,680.7 Million in 2025, expanding to a CAGR of 8.9% from 2026 to 2033.

Genomic cancer panels and profiling are advanced diagnostic techniques used to analyze the genetic composition of a patient’s tumor. These tests examine DNA, RNA, and other molecular biomarkers to identify genetic alterations that may be driving cancer development and progression. By leveraging next-generation sequencing (NGS) technologies, genomic profiling can simultaneously evaluate multiple genes and detect a wide range of abnormalities, including mutations, gene fusions, copy number variations, and other clinically relevant genomic changes. The insights generated through these tests enable healthcare professionals to better understand the unique molecular characteristics of each cancer case, supporting more precise diagnosis and personalized treatment planning. This approach is playing a key role in advancing precision oncology by helping clinicians select targeted therapies that are more effective and tailored to individual patients.

From a global healthcare and regulatory perspective, government health agencies and research organizations—such as the U.S. National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA)—are actively supporting the integration of genomic testing into clinical practice. In addition, national cancer control programs and public health initiatives across multiple countries are increasingly promoting early cancer detection and precision medicine approaches, further driving the adoption of genomic cancer profiling technologies worldwide.

Genomic Cancer Panel and Profiling Market- Market Dynamics

Rising Demand for Cloud-Native Applications, Automation, and AI Integration Driving Market Growth

One of the key factors driving the growth of the genomic cancer panel and profiling market is the rising adoption of precision oncology. Cancer treatment is increasingly shifting from a generalized approach to highly personalized therapies tailored to the genetic profile of an individual’s tumor. Genomic profiling enables oncologists to identify actionable mutations, gene fusions, and other clinically significant molecular biomarkers that influence cancer development and progression. This supports the selection of targeted therapies and immunotherapies, improving treatment effectiveness while reducing reliance on less suitable or less effective treatment options. The growing global burden of cancer is further accelerating market expansion. According to the World Health Organization (WHO), cancer cases are projected to rise significantly, with an estimated 35 million new cases expected annually by 2050, highlighting the urgent need for advanced diagnostic and personalized treatment solutions.

As cancer incidence continues to increase worldwide, healthcare systems are placing greater emphasis on advanced diagnostic tools that enable earlier and more accurate treatment planning. Genomic cancer profiling allows clinicians to identify optimal therapeutic strategies at earlier stages, reduce trial-and-error approaches, and improve patient selection for clinical trials. In addition, the expanding availability of targeted oncology therapies and companion diagnostics is strengthening the clinical importance of molecular profiling, making it an essential part of modern cancer care pathways.

The market is also benefiting from continuous advancements in genomic sequencing technologies, particularly next-generation sequencing (NGS). Improvements in sequencing speed, accuracy, scalability, and bioinformatics analysis have significantly enhanced the ability to detect cancer-related genetic alterations. Increasing automation in laboratory workflows has further streamlined testing processes, enabling faster turnaround times and improved operational efficiency. As a result, genomic profiling is being increasingly integrated into routine oncology diagnosis and treatment planning, thereby supporting sustained market growth globally.

Genomic Cancer Panel and Profiling Market- Segmentation Analysis:
The Global Genomic Cancer Panel and Profiling Market is segmented on the basis of Testing Type, Technology, Cancer Type, End-Use, Application, and Region.

The market for genomic cancer profiling can be segmented into several testing types, including Comprehensive Genomic Profiling (CGP), Targeted Gene Panels, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), liquid biopsy-based profiling, solid tumor biopsy-based profiling, and other emerging approaches. Among these, CGP accounts for a significant share of the market due to its ability to deliver an extensive molecular overview of cancer in a single test. According to global public health estimates from the World Health Organization, cancer remains a major burden worldwide, with around 20 million new cases and nearly 10 million deaths reported annually, highlighting the growing need for advanced diagnostic tools.

Comprehensive Genomic Profiling is preferred over more limited approaches such as targeted gene panels because it evaluates hundreds of cancer-associated genes simultaneously, rather than focusing on a predefined set. This enables the detection of diverse genomic alterations, including mutations, copy number variations, and gene rearrangements, providing a more complete understanding of tumor biology and supporting personalized treatment strategies. Global health agencies also note a continuous rise in the adoption of molecular and precision diagnostics in oncology, driven by the increasing demand for more accurate and individualized cancer care solutions.

Genomic Cancer Panel and Profiling Market- Geographical Insights

North America’s genomic cancer profiling market is expanding significantly due to the growing integration of precision medicine into everyday oncology practice. Major cancer research institutes, academic hospitals, and specialized oncology centers are increasingly relying on genomic profiling to design more personalized treatment strategies for patients. Strong collaboration among healthcare providers, research organizations, and industry players has further accelerated the development and adoption of advanced genomic testing solutions, strengthening the region’s precision oncology ecosystem and supporting wider clinical use of comprehensive genomic profiling.

In Europe, market growth is primarily driven by the rising adoption of liquid biopsy technologies and other advanced genomic analysis tools. Healthcare providers are increasingly shifting toward blood-based testing as a minimally invasive alternative to traditional tissue biopsies, especially for cancer detection, ongoing disease monitoring, and assessment of treatment response. In addition, the use of artificial intelligence, machine learning, and advanced bioinformatics is enhancing the interpretation of complex genomic data, enabling faster and more precise clinical insights. These technological advancements are improving decision-making in oncology and contributing to the broader acceptance of genomic profiling across the region.

United States Genomic Cancer Panel and Profiling Market- Key Insights

The United States represents a leading market for genomic cancer panels and profiling, driven by its strong focus on precision medicine, advanced healthcare infrastructure, and widespread adoption of molecular diagnostic technologies in oncology. As cancer care continues to shift toward biomarker-guided treatment approaches, genomic testing is increasingly being incorporated into routine clinical decision-making to support more personalized therapy selection. The rising incidence of cancer further reinforces this demand. According to the American Cancer Society, over 2 million new cancer cases are projected each year in the United States, highlighting the growing need for more accurate and individualized diagnostic solutions. Additionally, the increasing number of FDA-approved targeted cancer therapies is strengthening the role of genomic profiling, as these tests are essential for identifying patients who are most likely to respond to specific treatments.

Genomic Cancer Panel and Profiling Market- Competitive Landscape:

The genomic cancer panel and profiling market is highly competitive, with diagnostic companies, sequencing technology providers, biotechnology firms, and specialized molecular testing laboratories all working to expand their presence in the rapidly growing precision oncology space. As demand for personalized cancer care increases, these players are investing heavily in broadening their testing portfolios, improving sequencing accuracy and efficiency, and advancing bioinformatics platforms that generate deeper, clinically meaningful insights into tumor genetics. A key area of focus is the development of comprehensive genomic profiling solutions that enable clinicians to identify actionable mutations and select the most appropriate targeted therapies or immunotherapies for individual patients. To support this, many diagnostic companies are forming strategic collaborations with pharmaceutical and biotechnology firms to co-develop companion diagnostics that help determine which patients are most likely to benefit from specific treatments.

Recent Developments:

  • In April 2025, Guardant Health announced a long-term partnership with Pfizer to advance precision oncology initiatives through its Infinity liquid biopsy platform. The collaboration leverages blood-based genomic testing and circulating tumor DNA (ctDNA) technologies to support biomarker discovery and patient stratification.

  • In May 2025, Illumina expanded its footprint in precision oncology by increasing the availability of its TruSight Oncology Comprehensive assay and strengthening reimbursement support for comprehensive genomic profiling services.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Guardant Health, Inc.
  • Exact Sciences Corporation
  • Foundation Medicine, Inc.
  • Caris Life Sciences
  • Tempus AI, Inc.
  • NeoGenomics Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • BGI Genomics Co., Ltd.
  • Personalis, Inc.
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2020-2033

  • Comprehensive Genomic Profiling (CGP)
  • Targeted Gene Panels
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence in Situ Hybridization (FISH)
  • Microarray Analysis
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Hematological Malignancies
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Clinical Diagnostic Laboratories
  • CROs
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Clinical Diagnostics
  • Biomarker Discovery
  • Companion Diagnostics
  • Drug Discovery & Development
  • Research Applications
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Genomic Cancer Panel and Profiling Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Genomic Cancer Panel and Profiling Market Snippet by Testing Type
2.1.2. Genomic Cancer Panel and Profiling Market Snippet by Technology
2.1.3. Genomic Cancer Panel and Profiling Market Snippet by Cancer Type
2.1.4. Genomic Cancer Panel and Profiling Market Snippet by End-Use
2.1.5. Genomic Cancer Panel and Profiling Market Snippet by Application
2.1.6. Genomic Cancer Panel and Profiling Market Snippet by Country
2.1.7. Genomic Cancer Panel and Profiling Market Snippet by Region
2.2. Competitive Insights
3. Genomic Cancer Panel and Profiling Key Market Trends
3.1. Genomic Cancer Panel and Profiling Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Genomic Cancer Panel and Profiling Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Genomic Cancer Panel and Profiling Market Opportunities
3.4. Genomic Cancer Panel and Profiling Market Future Trends
4. Genomic Cancer Panel and Profiling Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Genomic Cancer Panel and Profiling Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Genomic Cancer Panel and Profiling Market Landscape
6.1. Genomic Cancer Panel and Profiling Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Genomic Cancer Panel and Profiling Market – By Testing Type
7.1. Overview
7.1.1. Segment Share Analysis, By Testing Type, 2025 & 2033 (%)
7.1.2. Comprehensive Genomic Profiling (CGP)
7.1.3. Targeted Gene Panels
7.1.4. Whole Genome Sequencing (WGS)
7.1.5. Whole Exome Sequencing (WES)
7.1.6. Others
8. Genomic Cancer Panel and Profiling Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. Next-Generation Sequencing (NGS)
8.1.3. Polymerase Chain Reaction (PCR)
8.1.4. Fluorescence in Situ Hybridization (FISH)
8.1.5. Microarray Analysis
8.1.6. Others
9. Genomic Cancer Panel and Profiling Market – By Cancer Type
9.1. Overview
9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
9.1.2. Breast Cancer
9.1.3. Lung Cancer
9.1.4. Colorectal Cancer
9.1.5. Prostate Cancer
9.1.6. Hematological Malignancies
9.1.7. Others
10. Genomic Cancer Panel and Profiling Market – By End-Use
10.1. Overview
10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Clinical Diagnostic Laboratories
10.1.4. CROs
10.1.5. Others
11. Genomic Cancer Panel and Profiling Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
11.1.2. Clinical Diagnostics
11.1.3. Biomarker Discovery
11.1.4. Companion Diagnostics
11.1.5. Drug Discovery & Development
11.1.6. Research Applications
11.1.7. Others
12. Genomic Cancer Panel and Profiling Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Genomic Cancer Panel and Profiling Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Genomic Cancer Panel and Profiling Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Genomic Cancer Panel and Profiling Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Genomic Cancer Panel and Profiling Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Genomic Cancer Panel and Profiling Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Genomic Cancer Panel and Profiling Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Illumina, Inc.
13.2.2. Thermo Fisher Scientific Inc.
13.2.3. F. Hoffmann-La Roche Ltd
13.2.4. QIAGEN N.V.
13.2.5. Agilent Technologies, Inc.
13.2.6. Guardant Health, Inc.
13.2.7. Exact Sciences Corporation
13.2.8. Foundation Medicine, Inc.
13.2.9. Caris Life Sciences
13.2.10. Tempus AI, Inc.
13.2.11. NeoGenomics Laboratories, Inc.
13.2.12. Myriad Genetics, Inc.
13.2.13. Natera, Inc.
13.2.14. BGI Genomics Co., Ltd.
13.2.15. Personalis, Inc.
13.2.16. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Guardant Health, Inc.
  • Exact Sciences Corporation
  • Foundation Medicine, Inc.
  • Caris Life Sciences
  • Tempus AI, Inc.
  • NeoGenomics Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • BGI Genomics Co., Ltd.
  • Personalis, Inc.
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2020-2033

  • Comprehensive Genomic Profiling (CGP)
  • Targeted Gene Panels
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence in Situ Hybridization (FISH)
  • Microarray Analysis
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Hematological Malignancies
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Clinical Diagnostic Laboratories
  • CROs
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Clinical Diagnostics
  • Biomarker Discovery
  • Companion Diagnostics
  • Drug Discovery & Development
  • Research Applications
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Request For Sample
Choose License Type
assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

Email:

[email protected]

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

QUICK LINKS
RESOURCES
Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved